Local recommendations (Nervous system)
For DMARD Shared Care click here
Antidepressants
| Recommendation | Approval date | Review date |
| Specialist Initiated Drugs Prescribing Information Sheet Bupropion EKPG | May 2018 | May 2021 |
| Patient information - changes to Trimipramine prescribing | April 2021 | |
| Trimipramine Audit - Patient information about reducing dose | April 2021 | |
| Trimipramine Audit - Patient information about switching to Sertraline | April 2021 | |
| Trimipramine Audit - Patient information about switching to Imipramine | April 2021 | |
| Trimipramine PrescQIPP Information | April 2021 | |
| Trimipramine briefing | April 2021 | |
| East Kent CCGs Protocol for the Management of Long Term Mental Health Conditions in Primary Care | April 2021 | |
| Vortioxetine Prescribing Guidelines - Feb 2019 | Feb 2019 | Feb 2022 |
| Agomelatine Prescribing Guidelines | May 2019 | May 2022 |
| Depression guidelines for primary care | April 2019 | April 2022 |
Anxiolytics, hypnotics and sedatives
| Recommendation | Approval date | Review date |
| Benzodiazepine and Z-hypnotic prescribing policy | June 2012 | April 2021 |
| PR 2021-10: Melatonin for sleep disorders in children with neurodevelopmental disorders | August 2021 | August 2022 |
| Chloral Hydrate in Children and Young People with Movement and Motor Disorders | April 2022 | April 2024 |
| Kent and Medway Melatonin Guidance | December 2023 | December 2025 |
| Melatonin Prescribing Checklist for Clinicians |
April 2024 | April 2026 |
Adult ADHD Prescribing
| Recommendation | Approval date | Review date |
| Adult ADHD Shared Care | December 2023 | December 2025 |
Dementia
| Recommendation | Approval date | Review date |
| BPSD Guidance for GPs | March 2022 | March 2024 |
| K&M Dementia Medication Prescribing Guidance | October 2023 | October 2025 |
Epilepsy
| Recommendation | Approval date | Review date |
| Brivaracetam Information Sheet | December 2021 | December 2023 |
| Buccal Midazolam for Patients with Epilepsy - EKPG Recommendation | June 2018 | June 2021 |
| Eslicarbazepine Prescribing Guidelines - EKPG | September 2014 | April 2021 |
| Lacosamide Prescribing Guidelines - EKPG | September 2014 | April 2021 |
| Zonisamide Prescribing Guidelines - EKPG | September 2014 | April 2021 |
| Kent and Medway Perampanel Prescribing Guidance | August 2022 | August 2024 |
| Cenobamate Prescribing v1.3 | August 2022 | August 2024 |
| Topiramate – Implementing MHRA Safety Measures in Kent & Medway |
August 2024 | August 2026 |
Movement disorders - Dystonias and Parkinson's Disease
| Recommendation | Approval date | Review date |
| Botulinum toxin for masseteric hypertrophy, EKPG Recommendation | June 2016 | April 2021 |
| Botulinum toxin for spasticity in adults, EKPG Recommendation | July 2016 | April 2021 |
| Botulinum toxin type A for blepharospasm EKPG Recommendation | June 2015 | April 2021 |
| Botulinum toxin type A for facial lines EKPG Recommendation | March 2016 | April 2021 |
| EKPG Recommendation, Botulinum Toxin for Frey's syndrome | May 2016 | April 2021 |
| EKPG Recommendation for Botulinum toxin for sialorrhoea in adults | September 2016 | April 2021 |
| Shared Care Guideline Riluzole | May 2018 | May 2021 |
| Co-careldopa intestinal gel (Duodopa) for the treatment of advanced Parkinsons disease EKPG | October 2013 | April 2021 |
| Kent and Medway PRGC Policy Recommendation. Botulinum neurotoxin (BoNT) for the management of cervical dystonias and hemifacial spasms in adults PR 2021-22 | April 2022 | April 2024 |
Cannabis based medicinal products
| Recommendation | Approval date | Review date |
| Cannabis-based-medication-desk-guide | November 2018 | November 2021 |
Pain
Psychoses and related disorders
| Recommendation | Approval date | Review date |
| Quetiapine Prescribing Guidelines | February 2015 | April 2021 |
| Minimum Physical Health Monitoring Requirements for Commonly Prescribed Psychotropic Medications | February 2017 | February 2020 |
| Lithium Treatment Pathway | December 2022 | December 2024 |
Sleep disorders
| Recommendation | Approval date | Review date |
| Sodium oxybate for the treatment of narcolepsy with cataplexy in adults EKPG recommendation | January 2016 | April 2021 |
Substance dependence
| Recommendation | Approval date | Review date |
| Public Health services commissioned by KCC - Stop Smoking. Information for GP practices EKPG | February 2018 | February 2021 |
Headache and Migraine
| Recommendation | Approval date | Review date |
| Management of Adults with Headaches and Migraines in Primary Care | August 2022 | August 2024 |
| Rimegepant for acute treatment of migraine – Guideline for Primary Care | June 2024 | June 2026 |
| Topiramate – Implementing MHRA Safety Measures in Kent & Medway | August 2024 | August 2026 |